119-HR-6238 DC Insider Whip Count Analysis

Bill and institutional context

H.R. 6238 (NIH IMPROVE Act) would authorize the NIH’s existing IMPROVE maternal health research initiative at $73.4M annually for FY2026–FY2031. The bill was introduced by Rep. Lauren Underwood with Rep. Brian Fitzpatrick on November 20, 2025; text mirrors the funding level and codifies the program. [2]Congress.gov — H.R.6238 - NIH IMPROVE Act (Congress.gov)

NIH’s IMPROVE initiative has operated since 2019 to reduce maternal mortality and severe morbidity, providing a mature programmatic base for authorization. [3]NIH NICHD — IMPROVE Initiative overview (NIH NICHD)

Companion bill S. 3254 was introduced by Sens. Katie Britt and Cory Booker, signaling bicameral, bipartisan intent. [4]Congress.gov — S.3254 - NIH IMPROVE Act (Congress.gov)

Institutional control: Republicans hold the Speakership (Mike Johnson) and Senate majority leadership (John Thune) in the 119th Congress; the White House is Republican (President Trump; Vice President Vance). These alignments matter for scheduling and UC negotiations. [5]Congress.gov — Congressional Record (Jan. 3, 2026) noting Speaker Mike Johnson

Breakdown: expected support by party/caucus

Signals point to broad bipartisan support; residual opposition (if any) would come from a small bloc of fiscal hard‑liners who resist new authorizations regardless of offsets. Evidence below.

• House Republicans: Strong support signaled by a 46–0 committee vote that included Chair Brett Guthrie and multiple conservative members voting Yea; expect leadership to route the bill on a low‑friction path (likely suspension). [1]U.S. House of Representatives — H.R. 6238 — E&C Roll Call Vote #11 (46–0) (PDF)
• House Democrats: Unanimous in committee; the lead sponsor is a Democrat and the policy sits squarely in caucus priorities on maternal health and equity. [1]U.S. House of Representatives — H.R. 6238 — E&C Roll Call Vote #11 (46–0) (PDF)
• Senate Republicans: Favorable posture—HELP Chair Bill Cassidy controls first gate and the Senate sponsor includes Republican Katie Britt. Cassidy’s gavel plus Thune’s floor control are material positives. [6]U.S. Senate HELP Committee — Senate HELP Committee — Members (Chair Cassidy)
• Senate Democrats/Independents: The Democratic co‑lead is Cory Booker; no ideological red flags. Expect broad support absent unrelated floor leverage. [7]Office of Sen. Cory Booker — Booker press release announcing S. 3254 (with Brit…
• External validators: March of Dimes is actively backing the authorization level and structure, lowering cross‑party risk. [8]March of Dimes — March of Dimes — NIH IMPROVE Act issue brief (Mar. 18, 2026)

Key legislators and leverage points

• House floor: Speaker Mike Johnson sets floor time; with a clean, unanimous committee record, he has multiple options (suspension/voice vote). [5]Congress.gov — Congressional Record (Jan. 3, 2026) noting Speaker Mike Johnson
• House managers: E&C Chair Brett Guthrie (R) and Ranking Member Frank Pallone (D) both voted Yea—useful for bipartisan floor messaging. [1]U.S. House of Representatives — H.R. 6238 — E&C Roll Call Vote #11 (46–0) (PDF)
• Bill sponsors: Rep. Lauren Underwood (D) and Rep. Brian Fitzpatrick (R) can expand the bipartisan cosponsor map and coordinate with outside groups to inoculate against process objections. [2]Congress.gov — H.R.6238 - NIH IMPROVE Act (Congress.gov)
• Senate gatekeeper: HELP Chair Bill Cassidy (R) controls markup/readout; his cooperation determines whether the Senate moves the House bill or advances S. 3254. [6]U.S. Senate HELP Committee — Senate HELP Committee — Members (Chair Cassidy)
• Senate floor: Majority Leader John Thune (R) decides floor time/UC posture; small‑ball health authorizations often move by unanimous consent if cleared. [9]U.S. Senate — U.S. Senate — Majority/Minority leaders list (Thune/Schumer)
• Senate leads: Sens. Katie Britt (R) and Cory Booker (D) provide bipartisan cover and can help clear holds within their respective conferences. [7]Office of Sen. Cory Booker — Booker press release announcing S. 3254 (with Brit…

Leadership stance and procedural dynamics

Committee posture is unequivocally positive: the House Energy & Commerce Committee ordered H.R. 6238 reported, 46–0, on May 21, 2026. That bipartisan unanimity typically qualifies a measure for the House suspension calendar (two‑thirds threshold) or a structured rule with minimal floor time. [1]U.S. House of Representatives — H.R. 6238 — E&C Roll Call Vote #11 (46–0) (PDF)

In the Senate, the HELP Committee is chaired by Sen. Bill Cassidy (R‑LA), and the chamber is run by Majority Leader John Thune (R‑SD). A non‑controversial, modest‑dollar NIH authorization with bipartisan sponsors (Britt/Booker) is a candidate for UC or quick voice vote once cleared through the hotline, provided there are no unrelated policy holds. [6]U.S. Senate HELP Committee — Senate HELP Committee — Members (Chair Cassidy)

Assessment and odds

• House: High likelihood of passage. A 46–0 committee vote creates momentum; expect minimal floor drama under GOP leadership. [1]U.S. House of Representatives — H.R. 6238 — E&C Roll Call Vote #11 (46–0) (PDF)
• Senate: Moderate‑to‑high likelihood. HELP Chair control and bipartisan sponsors are favorable; the main risk is calendar congestion or unrelated holds rather than bill substance. [6]U.S. Senate HELP Committee — Senate HELP Committee — Members (Chair Cassidy)
• White House: Alignment with a Republican administration reduces veto risk; no adverse SAP is evident to date. [10]The White House — WhiteHouse.gov — President Donald J. Trump

Bottom line: Expect enactment this work period or via a year‑end health package if the stand‑alone path slips; confidence: high for House, moderate‑high for Senate.

Core sources

Key references underpinning the whip estimate and procedural map.

• Congress.gov bill page and text for H.R. 6238 (intro date; committee referral; statutory language). [2]Congress.gov — H.R.6238 - NIH IMPROVE Act (Congress.gov)
• House E&C Committee Repository (agenda, vote file showing 46–0). [11]U.S. House of Representatives — House E&C Full Committee Markup (May 21, 2026)…
• Senate companion and sponsors (S. 3254) via Congress.gov and sponsor press materials. [4]Congress.gov — S.3254 - NIH IMPROVE Act (Congress.gov)
• Senate HELP Committee leadership/membership (chair’s gavel). [6]U.S. Senate HELP Committee — Senate HELP Committee — Members (Chair Cassidy)
• Chamber leadership (Speaker Mike Johnson; Majority Leader John Thune). [5]Congress.gov — Congressional Record (Jan. 3, 2026) noting Speaker Mike Johnson
• White House occupants (President Trump; Vice President Vance). [10]The White House — WhiteHouse.gov — President Donald J. Trump
• Program background: NIH/NICHD on the IMPROVE initiative. [3]NIH NICHD — IMPROVE Initiative overview (NIH NICHD)
• Interest‑group support: March of Dimes issue brief backing H.R. 6238/S. 3254. [8]March of Dimes — March of Dimes — NIH IMPROVE Act issue brief (Mar. 18, 2026)